Salarius Pharmaceuticals, Inc. — Director's Dealing 2019

Sep 13, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Salarius Pharmaceuticals, Inc. (SLRX)
CIK: 0001615219
Period of Report: 2019-09-10

Reporting Person: Northrup Jonathan P (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-09-10	Stock Option (right to buy)	$8.0	A	3000	Acquired	2029-09-10	Common Stock (3000.0)	Direct